Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zhende Medical CoSHSE:603301 -3.46%53 EBITDA Margin % is 9.37% as of Jun. 2026, which is 44% below its 10-year median of 16.81. GuruFocus rates SHSE:603301 with a GF Score™ of 53/100 and a GF Value™ of ¥26.63 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 814 Medical Devices & Instruments companies, Zhende Medical Co ranks better than 50.37% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Zhende Medical Co's EBITDA for the
three
months ended in Jun. 2026 was ¥115 Mil. Zhende Medical Co's Revenue for the
three
months ended in Jun. 2026 was ¥1,224 Mil. Therefore, Zhende Medical Co's EBITDA margin for the quarter that ended in Jun. 2026 was 9.37%.
Zhende Medical Co (SHSE:603301) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Zhende Medical Co EBITDA Margin % Related Terms
Zhende Medical Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Zhende Medical Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:603301 vs ISRG, BDX, RMD: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, Zhende Medical Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhende Medical Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Zhende Medical Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Zhende Medical Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhende Medical Co (SHSE:603301) has a EBITDA Margin % of 9.37% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Zhende Medical Co and its competitors. This is 44% below median its historical median of 16.81. Over the past decade, Zhende Medical Co's EBITDA Margin % has ranged from 8.41 to 34.91. According to the industry distribution chart, Zhende Medical Co ranks #404 out of 814 companies in the Medical Devices & Instruments industry, placing it in the top 49.6%.
Is Zhende Medical Co's EBITDA Margin % too high?
Zhende Medical Co's current EBITDA Margin % of 9.37% is 44% below median its 10-year median of 16.81. Over the past 10 years, this metric has ranged from a low of 8.41 to a high of 34.91. The Medical Devices & Instruments industry median EBITDA Margin % is 7.98. Zhende Medical Co's value of 9.37% is 17.4% above this industry median. Based on the distribution chart, Zhende Medical Co ranks #404 out of 814 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Zhende Medical Co has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zhende Medical Co's EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Zhende Medical Co ranks #404 out of 814 companies for EBITDA Margin %. This puts Zhende Medical Co in the upper half of its industry. The industry median EBITDA Margin % is 7.98. Zhende Medical Co's value of 9.37% is 17.4% above this benchmark. Historically, Zhende Medical Co's own EBITDA Margin % has ranged from 8.41 to 34.91 over the past decade. While the company's 10-year median is 16.81 vs. the industry median of 7.98, Zhende Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.98, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhende Medical Co's current EBITDA Margin % of 9.37% is 17.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Zhende Medical Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhende Medical Co's current EBITDA Margin % is 9.37%, which is 44% below median its own 10-year median of 16.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhende Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Zhende Medical Co (SHSE:603301) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥26.63, compared to a current price of ¥81.24 — trading 205.1% above its estimated fair value. The current EBITDA Margin % is 9.37%, which is 44% below median its 10-year median of 16.81 and 17.4% above the Medical Devices & Instruments industry median of 7.98. Zhende Medical Co's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Zhende Medical Co (SHSE:603301), the current EBITDA Margin % is 9.37% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhende Medical Co (SHSE:603301) Overvalued in 2026?
Based on GuruFocus' analysis, Zhende Medical Co stock appears to be overvalued.
The current stock price of ¥81.24 is trading 205.1% above its estimated GF Value™ of ¥26.63.
GuruFocus considers Zhende Medical Co to be Significantly Overvalued.
Key valuation signals for SHSE:603301:
EBITDA Margin %: 9.37% (44% below median its 10-year median of 16.81)
GF Value™: ¥26.63 vs. price of ¥81.24 (205.1% above fair value)
Industry Position: 17.4% above the Medical Devices & Instruments median (#404 of 814)
No single metric tells the full story. See the SHSE:603301 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhende Medical Co Ltd operates as a supplier of medical care and protection in China. The company is engaged in the production and sales of medical dressings. Its product categories are basic medical dressings, operating room sensory control, pressure therapy and fixation, stoma and chronic wounds, Isolation protection, and personal protection.
53GF Score
Get the complete analysis for SHSE:603301
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603301 has been successfully added to your 
